CG-SUO-CTC

CytoGen is a South Korean biotechnology company specializing in liquid biopsy technology, specifically the isolation and analysis of Circulating Tumor Cells (CTC). The company's core platform, Smart Biopsy, utilizes a proprietary high-density micropore filter (HDM Filter) to capture live CTCs from blood samples with high efficiency and purity. This technology enables real-time monitoring of cancer progression, treatment response, and the identification of therapeutic targets without the need for invasive tissue biopsies. CytoGen provides comprehensive services including CTC enumeration, molecular characterization, and drug sensitivity testing to support both clinical diagnostics and pharmaceutical drug development.